Outlook Therapeutics
OTLK
$8.65
Share price
-3.03%
Change (1 day)
639.32%
Change (1 year)
Categories
Outlook Therapeutics (OTLK) Fails to deliver data
Key failure to deliver metrics for Outlook Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.72 M
- Last year FTD volume: $8.5 M
Failures to deliver for Outlook Therapeutics (OTLK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Outlook Therapeutics (OTLK) - since 2019
Volume in USD (price x number of shares), data since 2019Outlook Therapeutics (OTLK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.77 M | -91.82% |
| 2023 | $9.49 M | 131.92% |
| 2022 | $4.09 M | -52.6% |
| 2021 | $8.64 M | 33.11% |
| 2020 | $6.49 M | -50.35% |
| 2019 | $13.07 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Organovo ONVO | $0.12 M | $0.76 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.21 M | $0.27 B | 🇬🇧 UK |
 Novavax NVAX | $37.88 M | $0.32 B | 🇺🇸 USA |
 Novocure
NVCR | $0.85 M | $7.42 M | Jersey |